Stock listing
NASDAQ:MPLT MapLight Therapeutics, Inc. Stock
Home listing (NASDAQ) of MapLight Therapeutics, Inc.
Follow MapLight Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MPLT
$8.24 USD +0.24 (+3.0%)
Close on Oct 20, 2026
- Day range
- $8.03 – $8.55 USDOct 20, 2026
- Volume
- 352,099 sharesOct 20, 2026
- Market cap
- $457.9M USDAt the close on Oct 20, 2026 · price × 55.58M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MPLT · Home | $8.24 USD | +0.24 (+3.0%) | 352,099 | $8.03 | $8.55 | $8.03 | $8.00 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:MPLT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.24 | +0.24 | +3.0% | $8.03 | $8.55 | $8.03 | 352,099 | |
| $8.00 | +0.30 | +3.9% | $7.73 | $8.07 | $7.66 | 278,655 | |
| $7.70 | -0.32 | -4.0% | $8.10 | $8.10 | $7.56 | 359,057 | |
| $8.02 | +0.21 | +2.7% | $7.84 | $8.34 | $7.743 | 658,421 | |
| $7.81 | -0.065 | -0.8% | $7.78 | $8.075 | $7.46 | 450,915 | |
| $7.875 | -0.725 | -8.4% | $8.60 | $8.60 | $7.85 | 301,710 | |
| $8.60 | -0.23 | -2.6% | $8.82 | $8.90 | $8.48 | 485,234 | |
| $8.83 | -0.32 | -3.5% | $9.15 | $9.415 | $8.70 | 495,355 | |
| $9.15 | -0.21 | -2.2% | $9.30 | $9.33 | $9.00 | 217,631 | |
| $9.36 | -0.33 | -3.4% | $9.62 | $9.88 | $9.30 | 275,186 | |
| $9.69 | +0.415 | +4.5% | $9.24 | $9.97 | $8.92 | 495,600 | |
| $9.275 | -0.545 | -5.5% | $9.80 | $9.80 | $9.19 | 262,000 | |
| $9.82 | +0.19 | +2.0% | $9.70 | $10.17 | $9.43 | 565,700 | |
| $9.63 | -0.56 | -5.5% | $10.16 | $10.17 | $9.57 | 432,200 | |
| $10.19 | +0.04 | +0.4% | $10.45 | $10.51 | $9.93 | 303,300 | |
| $10.15 | -0.30 | -2.9% | $10.64 | $10.64 | $10.12 | 408,300 | |
| $10.45 | -0.01 | -0.1% | $10.39 | $10.59 | $10.15 | 251,600 | |
| $10.46 | -0.30 | -2.8% | $10.81 | $10.87 | $10.39 | 317,500 | |
| $10.76 | -0.01 | -0.1% | $10.60 | $10.86 | $10.16 | 341,800 | |
| $10.77 | -0.09 | -0.8% | $10.89 | $10.93 | $10.13 | 539,000 | |
| $10.86 | -0.04 | -0.4% | $11.02 | $11.28 | $10.64 | 411,300 | |
| $10.90 | -0.02 | -0.2% | $11.06 | $11.28 | $10.78 | 542,900 | |
| $10.92 | -0.40 | -3.5% | $11.21 | $11.21 | $10.51 | 1,832,900 | |
| $11.32 | -0.08 | -0.7% | $11.57 | $11.73 | $11.13 | 545,900 | |
| $11.40 | -0.68 | -5.6% | $12.06 | $12.16 | $11.35 | 613,900 | |
| $12.08 | -1.07 | -8.1% | $13.10 | $13.11 | $12.05 | 402,300 | |
| $13.15 | +0.15 | +1.2% | $13.08 | $13.45 | $12.66 | 327,600 | |
| $13.00 | -0.785 | -5.7% | $13.88 | $14.14 | $12.80 | 340,200 | |
| $13.79 | +0.075 | +0.5% | $13.49 | $14.04 | $13.19 | 490,300 | |
| $13.71 | -0.24 | -1.7% | $13.95 | $14.22 | $13.51 | 500,200 | |
| $13.95 | +0.18 | +1.3% | $13.49 | $14.09 | $13.19 | 522,000 | |
| $13.77 | +0.63 | +4.8% | $13.03 | $14.14 | $13.00 | 550,900 | |
| $13.14 | +0.08 | +0.6% | $13.20 | $13.45 | $12.96 | 863,500 | |
| $13.06 | -0.25 | -1.9% | $13.33 | $13.94 | $12.82 | 937,700 | |
| $13.31 | +0.34 | +2.6% | $12.99 | $13.93 | $12.32 | 580,700 | |
| $12.97 | +0.37 | +2.9% | $12.59 | $13.07 | $12.12 | 440,600 | |
| $12.60 | +0.06 | +0.5% | $12.65 | $12.84 | $12.20 | 375,100 | |
| $12.54 | -0.32 | -2.5% | $12.87 | $13.24 | $12.50 | 741,500 | |
| $12.86 | +0.32 | +2.6% | $12.47 | $12.95 | $11.71 | 910,000 | |
| $12.54 | +1.18 | +10.4% | $11.47 | $12.74 | $11.35 | 703,481 | |
| $11.36 | +0.15 | +1.3% | $11.21 | $11.44 | $10.51 | 563,455 | |
| $11.21 | -0.02 | -0.2% | $11.35 | $11.61 | $11.07 | 435,400 | |
| $11.23 | -0.92 | -7.6% | $12.07 | $12.21 | $10.96 | 555,300 | |
| $12.15 | +0.33 | +2.8% | $12.11 | $12.32 | $11.69 | 896,400 | |
| $11.82 | +0.575 | +5.1% | $11.20 | $11.93 | $11.08 | 547,800 | |
| $11.25 | -0.505 | -4.3% | $11.76 | $11.79 | $10.96 | 620,500 | |
| $11.75 | +0.17 | +1.5% | $12.04 | $12.25 | $11.23 | 451,800 | |
| $11.58 | +0.20 | +1.8% | $11.92 | $12.32 | $11.51 | 501,200 | |
| $11.38 | -0.60 | -5.0% | $12.15 | $12.32 | $11.33 | 478,300 | |
| $11.98 | -0.20 | -1.6% | $12.16 | $12.29 | $11.59 | 359,000 | |
| $12.18 | +0.01 | +0.1% | $11.06 | $12.52 | $10.84 | 552,200 | |
| $12.17 | -1.11 | -8.4% | $13.28 | $13.61 | $12.09 | 432,500 | |
| $13.28 | +0.36 | +2.8% | $12.76 | $13.74 | $12.71 | 476,700 | |
| $12.92 | -0.02 | -0.2% | $13.32 | $13.39 | $12.76 | 886,900 | |
| $12.94 | +0.39 | +3.1% | $12.57 | $13.03 | $12.37 | 847,600 | |
| $12.55 | -0.47 | -3.6% | $12.85 | $13.14 | $12.08 | 999,900 | |
| $13.02 | -1.01 | -7.2% | $14.42 | $14.99 | $13.00 | 1,149,100 | |
| $14.03 | -0.99 | -6.6% | $15.17 | $15.50 | $13.51 | 3,152,600 | |
| $15.02 | +2.71 | +22.0% | $12.63 | $16.07 | $12.56 | 3,089,600 | |
| $12.31 | +2.405 | +24.3% | $9.56 | $12.31 | $9.10 | 5,540,200 | |
| $9.905 | -26.66 | -72.9% | $12.98 | $14.50 | $9.905 | 8,148,100 | |
| $36.56 | +1.33 | +3.8% | $35.46 | $36.97 | $34.38 | 547,400 | |
| $35.23 | -0.08 | -0.2% | $34.86 | $36.04 | $34.50 | 376,400 | |
| $35.31 | -2.13 | -5.7% | $37.70 | $37.70 | $35.28 | 265,900 | |
| $37.44 | +1.45 | +4.0% | $37.30 | $38.26 | $36.03 | 557,563 | |
| $35.99 | -1.88 | -5.0% | $38.11 | $38.93 | $35.97 | 599,335 |
- Ticker
- NASDAQ:MPLT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
Latest deck · Aug 13, 2026
Investor Presentation (August 2026)
Investor deck · 28 slides
Latest news
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
Oct 6, 2026
Closed $9.69 (+4.5%) on Oct 6, 2026
MapLight Therapeutics to Participate in Upcoming Investor Conference
Sep 9, 2026
Closed $13.71 (-1.7%) on Sep 9, 2026
MapLight Therapeutics Announces $150 Million Private Placement Financing
Aug 13, 2026
Closed $11.58 (+1.8%) on Aug 13, 2026
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
Jul 27, 2026
Closed $9.91 (-72.9%) on Jul 27, 2026
Financings
Private placement of common stock and pre-funded warrants
Aug 13, 2026
Announced: about US$150M · US$11.38 a share · Morgan Stanley +3
Dealers: Morgan Stanley, Jefferies, Leerink Partners, Stifel
Use of proceeds: Advance ML-007C-MA, including the VISTA Phase 2 and ZEPHYR-2 Phase 3 studies, plus working capital and general corporate purposes
Decks
Investor Presentation (August 2026)
Investor deck · 28 slides · Aug 13, 2026
Technical Presentation (July 2026)
Technical · 27 slides · Jul 27, 2026
Technical Presentation (June 2026)
Technical · 21 slides · Jun 22, 2026
Investor Presentation (May 2026)
Investor deck · 34 slides · May 14, 2026
MapLight Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 16 in all · newest Oct 6, 2026 · oldest 2025
- Decks
- 7 decks · latest Aug 13, 2026
Where MapLight Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MPLT · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MPLT | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about MapLight Therapeutics, Inc.